Clinical Trial Update: Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD) [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether cilostazol affects endothelial progenitor cells and collateral vessel formation in peripheral artery disease. The study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Pletal (cilostazol) (cilostazol)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Peripheral Arterial Diseases | Phase 4 | Status: COMPLETED